Cargando…

A Precision Medicine Approach to Treating Alzheimer’s Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials

BACKGROUND: The REFLECT trials were conducted to examine the treatment of mild-to-moderate Alzheimer’s disease utilizing a peroxisome proliferator-activated receptor gamma agonist. OBJECTIVE: To generate a predictive biomarker indicative of positive treatment response using samples from the previous...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Bryant, Sid E., Zhang, Fan, Petersen, Melissa, Johnson, Leigh, Hall, James, Rissman, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8203239/ https://www.ncbi.nlm.nih.gov/pubmed/33814447 http://dx.doi.org/10.3233/JAD-201610

Ejemplares similares

Combination of Serum and Plasma Biomarkers Could Improve Prediction Performance for Alzheimer’s Disease
por: Zhang, Fan, et al.
Publicado: (2022)

Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort
por: Hall, James R., et al.
Publicado: (2022)

Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer’s Disease With High Performance Computing
por: Zhang, Fan, et al.
Publicado: (2021)

Hyperparameter Tuning with High Performance Computing Machine Learning for Imbalanced Alzheimer’s Disease Data
por: Zhang, Fan, et al.
Publicado: (2022)

Depression is differentially related to cognitive and biomarker outcomes among Mexican Americans
por: O’Bryant, Sid E., et al.
Publicado: (2022)

Association of cardiovascular risk factors and blood biomarkers with cognition: The HABS‐HD study
por: Jiang, Xiaqing, et al.
Publicado: (2023)

APOEε4 Genotype Is Related to Brain Amyloid Among Mexican Americans in the HABS-HD Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

A Depressive Endophenotype of Mild Cognitive Impairment and Alzheimer’s Disease
por: Johnson, Leigh A., et al.
Publicado: (2013)

Characterizing plasma NfL in a community‐dwelling multi‐ethnic cohort: Results from the HABLE study
por: O'Bryant, Sid, et al.
Publicado: (2021)

Plasma Total Tau and Neurobehavioral Symptoms of Cognitive Decline in Cognitively Normal Older Adults
por: Hall, James R., et al.
Publicado: (2021)

Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease
por: O'Bryant, Sid E.
Publicado: (2016)

Parkinson’s Disease Blood Test for Primary Care
por: O’Bryant, Sid E., et al.
Publicado: (2022)

Application of Structural Retinal Biomarkers to Detect Cognitive Impairment in a Primary Care Setting
por: Mozdbar, Sima, et al.
Publicado: (2022)

Depressive Symptom Clusters and Neuropsychological Performance in Mild Alzheimer's and Cognitively Normal Elderly
por: Hall, James R., et al.
Publicado: (2011)

Neurodegeneration from the AT(N) framework is different among Mexican Americans compared to non‐Hispanic Whites: A Health & Aging Brain among Latino Elders (HABLE) Study
por: O'Bryant, Sid E., et al.
Publicado: (2022)

Molecular markers of neuropsychological functioning and Alzheimer's disease
por: Edwards, Melissa, et al.
Publicado: (2015)

Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study
por: O'Bryant, Sid E., et al.
Publicado: (2019)

A blood screening tool for detecting mild cognitive impairment and Alzheimer's disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research
por: O'Bryant, Sid E., et al.
Publicado: (2021)

The relationship of CRP and cognition in cognitively normal older Mexican Americans: A cross-sectional study of the HABLE cohort
por: Vintimilla, Raul, et al.
Publicado: (2019)

Cardiovascular Risk Factors, Cognitive Dysfunction, and Mild Cognitive Impairment
por: Vintimilla, Raul, et al.
Publicado: (2020)

Subjective cognitive complaints and cardiovascular risk factors in older Mexican Americans: A cross-sectional study.
por: Vintimilla, Raul, et al.
Publicado: (2022)

Cardiovascular Risk Factors and Cognitive Performance in Cognitively Normal Non-Hispanic Whites and Mexican Americans From the HABS-HD Cohort
por: Vintimilla, Raul, et al.
Publicado: (2022)

Association of Area Deprivation Index and hypertension, diabetes, dyslipidemia, and Obesity: A Cross-Sectional Study of the HABS-HD Cohort
por: Vintimilla, Raul, et al.
Publicado: (2023)

A blood screening test for Alzheimer's disease
por: O'Bryant, Sid E., et al.
Publicado: (2016)

Total testosterone and neuropsychiatric symptoms in elderly men with Alzheimer’s disease
por: Hall, James R, et al.
Publicado: (2015)

Depression, inflammation, and memory loss among Mexican Americans: analysis of the HABLE cohort
por: Johnson, Leigh A., et al.
Publicado: (2017)

Factores de riesgo cardiovascular en Estados Unidos y México: comparación de los estudios HABLE y ENASEM
por: Vintimilla, Raúl, et al.
Publicado: (2020)

Factor structure and measurement invariance of a neuropsychological test battery designed for assessment of cognitive functioning in older Mexican Americans
por: Gavett, Brandon E., et al.
Publicado: (2018)

Proteomic profiles of prevalent mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: Petersen, Melissa, et al.
Publicado: (2020)

MRI biomarkers of small vessel disease and cognition: A cross‐sectional study of a cognitively normal Mexican American cohort
por: Vintimilla, Raul, et al.
Publicado: (2021)

Evaluation of Neighborhood-Level Disadvantage and Cognition in Mexican American and Non-Hispanic White Adults 50 Years and Older in the US
por: Wong, Christina G., et al.
Publicado: (2023)

Arsenic exposure, AS3MT polymorphism, and neuropsychological functioning among rural dwelling adults and elders: a cross-sectional study
por: Edwards, Melissa, et al.
Publicado: (2014)

Reflections on the Utility of the Retina as a Biomarker for Alzheimer’s Disease: A Literature Review
por: Ngolab, Jennifer, et al.
Publicado: (2019)

Inflammatory Biomarkers, Depressive Symptoms and Falls among the Elderly in Panama
por: Britton, Gabrielle B., et al.
Publicado: (2018)

Comparing biological markers of Alzheimer's disease across blood fraction and platforms: Comparing apples to oranges
por: O'Bryant, Sid E., et al.
Publicado: (2015)

The Link between Cognitive Measures and ADLs and IADL Functioning in Mild Alzheimer's: What Has Gender Got to Do with It?
por: Hall, James R., et al.
Publicado: (2011)

Serum Granulocyte Colony-Stimulating Factor and Alzheimer's Disease
por: Barber, Robert C., et al.
Publicado: (2012)

Proteomic profiles of incident mild cognitive impairment and Alzheimer's disease among adults with Down syndrome
por: O'Bryant, Sid E., et al.
Publicado: (2020)

Circulating mitochondrial DNA: New indices of type 2 diabetes-related cognitive impairment in Mexican Americans
por: Silzer, Talisa, et al.
Publicado: (2019)

Association Between Cognitive Impairment and Chronic Kidney Disease in Mexican Americans
por: Szerlip, Harold M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ct1dutc7gd4ae99afqvhh60qv7